Brief: Dare Bioscience Says On July 19, Co Got Notice Of Failure To Satisfy Continued Listing Rule Or Standard Transfer Of Listing From Nasdaq
July 21 (Reuters) - Dare Bioscience Inc DARE.O :
* DARE BIOSCIENCE INC - ON JULY 19, CO GOT NOTICE OF FAILURE
TO
SATISFY CONTINUED LISTING RULE OR STANDARD; TRANSFER OF LISTING
FROM NASDAQ
Further company coverage: DARE.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Dare Bioscience
See all newsBrief: Dare Bioscience - Files For Resale Of Up To 8,934,345 Shares Of Common Stock - SEC Filing
Brief: Daré Bioscience CEO Sabrina Martucci Johnson Named To Forbes 2026 “50 Over 50 Innovation” List
NASDAQ RESUMED AT 12:50 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:45 PM
Dare Bioscience Inc reports results for the quarter ended June 30 - Earnings Summary